Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.


Home > Oncology > SABCS 2019 > HER2-Positive Breast Cancer > Higher age means higher risk for breast cancer patients

Higher age means higher risk for breast cancer patients

Conference
SABCS 2019
    Elderly patients with breast cancer experience significantly worse survival when they receive less than standard systemic treatment, or have second primary disease other than breast cancer in their follow-up period.

    Age is one of the most significant risk factors for breast cancer and, although proportional incidence is uncertain, the absolute number of elderly patients is increasing. The aim of the study conducted by Moon et al. was to outline breast cancer in elderly (Korean) patients and examine survival by clinicopathologic factors such as age, stage, and disease subtype [1]. A total of 1,103 patients who were diagnosed with and completed their primary treatment for breast cancer between 2000 and 2013 were included. Clinicopathologic data was collected with retrospective data review. Survival data and risk factors - if the survival was statistically significant - were obtained. Mean age of the patients was 52.71 years (range 22-89) and subjects were divided into 3 groups: women aged <40 years (n=134), women aged 40-60 years (n=508), and women aged >60 years (n=191).

    The worse prognosis of elderly patients with triple-negative breast cancer who got less than standard systemic treatment (HR 4.84; 95% CI 1.51-15.45) and had secondary disease other than breast cancer (HR 2.40; 95% CI; 1.11-5.19) were significantly correlated with higher mortality in elderly patients (see Figure).

    Figure. Cox proportional hazard ratio for the multivariate risk factor analysis [1]



    ER, oestrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2

    1. Moon G, et al. P3-08-72. SABCS 2019.




    Posted on